Clinical Trials Browser

Uterine Neoplasms

NCT05743517 2026-05-29

Physical Activity Intervention Among Older Women With Gynecologic Cancers (Fit4Treatment)

Uterine Cervical Neoplasms, Motor Activity, Ovarian Neoplasms, Uterine Neoplasms, Vaginal Neoplasms, Vulvar Neoplasms, Endometrial Neoplasms

NCT04634617 2026-05-20

Pelvic Floor Dysfunction and Quality of Life in Uterine Cancer Survivors

Active not recruiting

310 enrolled

Gynecologic

Uterine Neoplasms, Endometrial Neoplasms

NCT06904365 2026-05-18

OvAR-Y

Active not recruiting

10 enrolled

BreastGastrointestinalGenitourinaryGynecologicHead & NeckSarcomaThoracic

Anus Neoplasms, Urinary Bladder Neoplasms, Breast Neoplasms, Uterine Cervical Neoplasms, Colonic Neoplasms, Head and Neck Neoplasms, Liver Neoplasms, Lung Neoplasms, Rectal Neoplasms, Sarcoma, Stomach Neoplasms, Uterine Neoplasms

NCT07581288 2026-05-12

MIRA

Not yet recruiting

50 enrolled

Gynecologic

Endometrial Hyperplasia, Metrorrhagia, Uterine Hemorrhage, Uterine Neoplasms, Endometrial Neoplasms

NCT05049538 2026-05-06

Determine the Utility of Liquid Biopsies and Tumor Molecular Profiling in Predicting Recurrence in Endometrial Cancers

Recruiting

1,000 enrolled

Gynecologic

Uterine Neoplasms

NCT06180733 2026-05-01

PAM-II

Phase 2 Active not recruiting

12 enrolled

GynecologicLymphoid

Lymphoma, Follicular, Uterine Neoplasms, Endometrial Neoplasms

NCT05559879 2026-04-15

Cabozantinib and Dostarlimab in Recurrent Gynecologic Carcinosarcoma

Phase 1/2 Recruiting

37 enrolled

Gynecologic

Carcinoma, Uterine Neoplasms, Endometrial Neoplasms

NCT07523152 2026-04-13

SAPPHIRE

Phase NA Not yet recruiting

42 enrolled

GastrointestinalGynecologic

Anal Canal Carcinoma, Anus Neoplasms, Pelvic Neoplasms, Uterine Neoplasms, Vaginal Neoplasms

NCT06447064 2026-03-25

(CLOCS-2)

Recruiting

2,900 enrolled

GastrointestinalGenitourinaryGynecologic

Urinary Bladder Neoplasms, Colonic Neoplasms, Esophageal Neoplasms, Liver Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms, Uterine Neoplasms, Vulvar Neoplasms, Endometrial Neoplasms

NCT05990426 2026-03-24

FAST

Phase NA Recruiting

30 enrolled

Gynecologic

Intermittent Fasting, Ovarian Neoplasms, Peripheral Nervous System Diseases, Uterine Neoplasms, Endometrial Neoplasms

NCT06662435 2026-03-23

GYNCOG

Phase NA Completed

60 enrolled

Gynecologic

Uterine Cervical Neoplasms, Ovarian Neoplasms, Uterine Neoplasms, Vulvar Neoplasms, Endometrial Neoplasms, Cognitive Dysfunction

NCT04038619 2026-03-20

Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients

Phase 1 Recruiting

40 enrolled

BreastDermatologicGynecologicThoracic

Breast Neoplasms, Uterine Cervical Neoplasms, Colitis, Diarrhea, Lung Neoplasms, Melanoma, Ovarian Neoplasms, Urogenital Neoplasms, Uterine Neoplasms

NCT03987555 2026-03-18

Paclitaxel Therapeutic Drug Monitoring in Cancer Patients

Suspended

22 enrolled

BreastGynecologicThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Lung Neoplasms, Ovarian Neoplasms, Uterine Neoplasms, Vulvar Neoplasms

Clinical Trials

[18F]FES PET/.CT in Uterine Cancer

Physical Activity Intervention Among Older Women With Gynecologic Cancers (Fit4Treatment)

Pelvic Floor Dysfunction and Quality of Life in Uterine Cancer Survivors

OvAR-Y

MIRA

Determine the Utility of Liquid Biopsies and Tumor Molecular Profiling in Predicting Recurrence in Endometrial Cancers

PAM-II

Cabozantinib and Dostarlimab in Recurrent Gynecologic Carcinosarcoma

SAPPHIRE

(CLOCS-2)

FAST

GYNCOG

Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients

Paclitaxel Therapeutic Drug Monitoring in Cancer Patients